Startseite
et-2862
Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke

4.7 (288) · € 21.50 · Auf Lager

Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome

Coagulation markers and functional outcome in acute ischemic stroke: Impact of intensive versus standard hyperglycemia control - Research and Practice in Thrombosis and Haemostasis

PDF) Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke: The European Cooperative Acute Stroke Study (ECASS)

Sex differences in IV thrombolysis treatment for acute ischemic stroke

Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator - ScienceDirect

Ischemic Stroke: Practice Essentials, Background, Anatomy

PDF) Does Sex Influence the Response to Intravenous Thrombolysis in Ischemic Stroke?: Answers From Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register

Coagulation biomarkers for ischemic stroke - Research and Practice in Thrombosis and Haemostasis

The Outcome of Treatment With Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke - Caspian Journal of Neurological Sciences

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis - The Lancet

Sex differences in thrombosis as it affects acute ischemic stroke - ScienceDirect

Tissue Plasminogen Activator for Acute Ischemic Stroke (Alteplase, Activase®)

JPM, Free Full-Text

Impact of sex in stroke thrombolysis: a coarsened exact matching study – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.